Miotepa 100 mg Injection BP is a potent chemotherapeutic agent containing Thiotepa, specifically designed for the treatment of various cancers, including those of the brain, breast, lungs, and ovaries. Produced by MBA Pharmaceuticals Pvt Ltd in India, this injection is often utilized in combination with other cancer therapies, particularly during hematopoietic progenitor cell transplantation (HPCT). Its administration is strictly supervised by healthcare professionals to ensure proper dosage and management of potential side effects. Common side effects have been noted, including decreased blood cell counts and elevated liver enzymes, necessitating regular monitoring throughout treatment. Miotepa is not recommended for use during pregnancy or breastfeeding and requires vigilant precautions for patient safety.
Key Features
| Features | Description |
|---|---|
| Composition | Thiotepa 100 mg |
| Packing | 1 Vial |
| Market Authorization | MBA Pharmaceuticals Pvt Ltd |
| Country of Origin | India |
| Used For | Treatment of brain, breast, lungs, and ovarian cancers |
| Administration | Administered by healthcare professionals |
| Combination Therapy | Often used with other cancer medications during HPCT |
| Attributes | Description |
|---|---|
| Formulation | Injection |
| Dosage Strength | 100 mg |
| Indications | Cancer treatment, specifically brain, breast, lung, and ovarian cancers |
| Common Side Effects | Decreased white blood cell count, Anemia, Low blood platelets, Increased liver enzymes, Elevated bilirubin levels, Mucosal inflammation, Hemorrhage, Diarrhea, Rash |
| Precautions | Inform doctor of any bleeding disorders or kidney/liver issues; avoid use during pregnancy and breastfeeding |
| Storage | Store in a cool, dry place away from light |
| Monitoring | Regular blood tests required for monitoring blood cell counts and organ function |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
Country Of Origin: India
Miotepa – Thiotepa 100 mg Injection BP
Miotepa 100 MG Injection
Composition: Thiotepa 100 mg
Packing: 1 Vial
Market Authorization: MBA Pharmaceuticals Pvt Ltd
Country of Origin: India
Miotepa 100mg Injection is used in the treatment of cancers of the brain, breast, lungs, and ovaries. It is often administered in combination with other cancer medications during hematopoietic progenitor cell transplantation (HPCT). Additionally, it may be used to treat other conditions as determined by your doctor.
Administration and Dosage
Miotepa 100mg – Thiotepa 100 mg Injection
Injection is generally administered under the supervision of a healthcare professional. Your doctor will determine the appropriate dose and duration of treatment based on the severity of your condition and the specific illness being treated. It may take several weeks or months to notice the benefits, but do not discontinue the injection unless advised by your doctor.
Common Side Effects
The most common side effects of Miotepa 100mg Injection include:
This medication may reduce the number of blood cells, increasing the risk of infections. Regular blood tests are required to monitor your blood cells, as well as kidney, liver, and heart function during treatment.
Precautions
Before starting treatment with Miotepa 100mg Injection, inform your doctor if you have any bleeding disorders, liver or kidney problems, or are taking any medications for infections. Miotepa can interact with many other medicines, so provide your doctor with a complete list of all the medications you are taking. This medicine is not recommended during pregnancy or while breastfeeding. Both males and females should use effective contraception during treatment to avoid pregnancy.
Inclusive of all taxes
You Save: 0
